BIOMARIN PHARMACEUTICAL H-1B Visa Sponsorship & Salary Data

The median H-1B salary at BIOMARIN PHARMACEUTICAL is $122,300, based on 148 certified filings from FY 2020 to FY 2026. This is 2% higher than the national H-1B median salary of $120,000. Compensation at BIOMARIN PHARMACEUTICAL reflects their market positioning, with entry-level roles starting around $101,899 and senior positions reaching $181,266 or higher. These figures represent base salaries in LCA filings and may not include bonuses, equity grants, or other compensation common at large employers.

Salaries at BIOMARIN PHARMACEUTICAL range from $86,424 at the 10th percentile to $181,266 at the 90th percentile, showing a $94,842 spread across experience levels and roles. The 25th percentile is $101,899 and the 75th percentile is $148,491.

Yes, BIOMARIN PHARMACEUTICAL actively sponsors H-1B visas and has been a consistent participant in the H-1B program. They have filed 154 H-1B labor condition applications from FY 2020 to FY 2026, demonstrating ongoing commitment to hiring international talent. With 148 certified applications and a 0.6% denial rate, BIOMARIN PHARMACEUTICAL maintains a strong track record for H-1B sponsorship. The company sponsors positions across multiple job categories and locations, making them a viable option for professionals seeking H-1B visa sponsorship.

In the most recent fiscal year (FY 2026), BIOMARIN PHARMACEUTICAL filed 3 H-1B applications, with 3 certified and 0 denied. Over 7 years of data, BIOMARIN PHARMACEUTICAL has consistently demonstrated commitment to H-1B sponsorship.

Note: These are Labor Condition Applications (LCAs) filed with the Department of Labor, which is a prerequisite for H-1B petitions. The actual number of H-1B petitions filed with USCIS may differ.

BIOMARIN PHARMACEUTICAL's LCA (Labor Condition Application) denial rate is 0.6%, with 1 out of 154 applications denied across all years. This translates to a 99.4% certification rate, which indicates how successfully the company prepares and files H-1B applications. A lower denial rate suggests better compliance with Department of Labor requirements, proper wage documentation, and accurate job classification. Prospective H-1B applicants should consider this approval rate alongside other factors like salary, job role, and location when evaluating BIOMARIN PHARMACEUTICAL as a potential H-1B sponsor.

This is a good approval rate, comparable to industry averages. BIOMARIN PHARMACEUTICAL demonstrates reliable H-1B sponsorship practices.

BIOMARIN PHARMACEUTICAL sponsors H-1B visas for various specialty occupation positions requiring at least a bachelor's degree. Based on 148 certified filings, the most commonly sponsored job titles reflect the company's primary business functions and talent needs. These positions typically require specialized knowledge in fields like technology, engineering, finance, or scientific research. Understanding which roles BIOMARIN PHARMACEUTICAL most frequently sponsors can help job seekers target their applications effectively.

Most common H-1B job titles at BIOMARIN PHARMACEUTICAL:

The most frequently sponsored role is Research Scientist with 37 filings at a median salary of $109,741. This is followed by Senior Research Associate (11 filings) and Senior Research Scientist.

BIOMARIN PHARMACEUTICAL's H-1B positions are distributed across multiple U.S. locations, with concentration in major metropolitan areas and tech hubs. Geographic distribution often reflects company office locations, client sites, and regional market demands. Location significantly impacts H-1B salary due to varying cost of living and local wage requirements. Understanding where BIOMARIN PHARMACEUTICAL sponsors H-1B workers can help candidates target specific offices and negotiate appropriate compensation for each market.

Top BIOMARIN PHARMACEUTICAL H-1B locations:

The largest H-1B hub for BIOMARIN PHARMACEUTICAL is San Rafael, CA with 83 filings at a median salary of $129,168. The highest-paying location is Brisbane, CA at $252,331 median. Salaries range from $70,308 to $252,331 across office locations.

BIOMARIN PHARMACEUTICAL's median H-1B salary has increased by +1% from FY 2020 ($114,442) to FY 2026 ($116,000). Tracking salary trends over time reveals how BIOMARIN PHARMACEUTICAL adjusts compensation to remain competitive in the H-1B labor market. Salary growth typically reflects inflation adjustments, increased demand for specialized skills, and evolving prevailing wage requirements. These historical trends can help applicants understand future salary expectations and negotiate appropriately when considering H-1B opportunities at BIOMARIN PHARMACEUTICAL.

Year-by-year breakdown:

• FY 2022: $128,752 (31 certified)
• FY 2023: $111,072 (21 certified)
• FY 2024: $109,928 (19 certified)
• FY 2025: $131,560 (27 certified)
• FY 2026: $116,000 (3 certified)

BIOMARIN PHARMACEUTICAL has maintained steady salary growth for H-1B positions over this period.

BIOMARIN PHARMACEUTICAL primarily files H-1B applications at Wage Level II, accounting for 42% of their filings. DOL wage levels range from Level I (entry-level, 17th percentile of local wages) to Level IV (expert, 67th percentile). Wage level determines both salary requirements and, under recent H-1B rules, lottery selection priority. Higher wage levels receive preference in the H-1B lottery, making BIOMARIN PHARMACEUTICAL's wage level distribution an important factor for prospective applicants assessing their chances of H-1B selection.

With 88% of positions at Level II or higher, BIOMARIN PHARMACEUTICAL typically offers competitive wages above entry-level. Higher wage levels receive priority in the H-1B lottery.

BIOMARIN PHARMACEUTICAL's median H-1B salary of $122,300 is 2% higher than the national H-1B median of $120,000 across all employers and industries. This comparison provides context for evaluating BIOMARIN PHARMACEUTICAL's competitiveness in attracting H-1B talent. Keep in mind that industry, location, and job function significantly impact salary levels. Tech companies and financial institutions typically offer higher H-1B salaries than other sectors, while salaries in major metros like San Francisco and New York exceed those in smaller markets. Compare BIOMARIN PHARMACEUTICAL's offerings with similar companies in your field for a more accurate assessment.

BIOMARIN PHARMACEUTICAL offers above-average H-1B compensation. Combined with their 148 certified filings and 0.6% denial rate, they demonstrate solid H-1B sponsorship practices.

Recent H-1B rule changes have increased filing fees and introduced wage-level prioritization in the lottery. BIOMARIN PHARMACEUTICAL files 12% of positions at Level I, which may face more lottery competition under wage-level prioritization rules.

With 148 certified filings, BIOMARIN PHARMACEUTICAL invests significantly in H-1B sponsorship. The company's 0.6% denial rate suggests strong compliance with H-1B requirements and documentation standards.

Note: H-1B regulations are subject to change. Fees shown are estimates based on 2024 USCIS fee schedules. Actual costs may vary based on company size, premium processing, and future rule changes.